Premium
Letter: immunogenicity of infliximab—ready for routine prediction?
Author(s) -
Amiot Aurelien
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15676
Subject(s) - medicine , immunogenicity , infliximab , biosimilar , immunology , antibody , tumor necrosis factor alpha